COMMUNIQUÉS West-GlobeNewswire
-
EUROBIO SCIENTIFIC : MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
29/04/2026 -
Syncromune®, Inc. Presents Innovative SYNC-T™ Combination Immunotherapy Approach at Major European Interventional Oncology Conference
29/04/2026 -
Cristcot to Present Oral Abstract at 2026 Digestive Disease Week (DDW)
29/04/2026 -
Press Release: Annual General Meeting of April 29, 2026 - Belén Garijo appointed as Director and Chief Executive Officer of Sanofi
29/04/2026 -
Communiqué de presse : Assemblée Générale Annuelle du 29 avril 2026 - Belén Garijo nommée administratrice et Directrice générale de Sanofi
29/04/2026 -
UroGen Pharma to Report First Quarter 2026 Financial Results on Wednesday, May 6th, 2026
29/04/2026 -
CorTec's Brain Interchange™ BCI System Enables Stroke Patient to Control Computer with his Mind
29/04/2026 -
Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142
29/04/2026 -
Anika Reports First Quarter 2026 Financial Results
29/04/2026 -
MindBio Files Patent Applications in 15 World Firsts
29/04/2026 -
EnteroBiotix Secures £19m to Initiate Phase 2b Clinical Trial for Irritable Bowel Syndrome
29/04/2026 -
Cronos Group Inc. to Hold Virtual 2026 Annual Meeting of Shareholders
29/04/2026 -
Ocugen to Host Conference Call on Tuesday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2026 Financial Results
29/04/2026 -
CorVel Corporation Launches CorVel Connected™, an AI-Powered Claims Intelligence Layer Embedded in CareMC®
29/04/2026 -
Ontario Building Code Review Points to a Clear Win for Families and Future Homeowners: Prevent Lung Cancer Cases by Keeping Radon Mitigation Measures in Place
29/04/2026 -
Calidi Biotherapeutics Announces Strategic Partnership with TransferAI to Drive Efficiencies in the IND Submission Process for CLD-401 Using Agentic AI
29/04/2026 -
Rein Therapeutics Provides Clinical Trial Update for Phase 2 RENEW Study of LTI-03 in Idiopathic Pulmonary Fibrosis
29/04/2026 -
Ultragenyx to Host Conference Call for First Quarter 2026 Financial Results and Corporate Update
29/04/2026 -
Inspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare Conference
29/04/2026
Pages